Search clinical trials for: Hydrochlorthiazide (HCTZ)

Total 561 results

Creighton University

Withdrawn

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

Hypertension

United States
Novartis

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Hypertension

Switzerland, Germany
Shiraz University of Medical Sciences

Completed

Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema

Edema | Nephrotic Syndrome
Takeda

Completed

Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

Safety

Ukraine, Germany, Poland, Bulgaria, Netherlands, Lithuania, Slovakia, Latvia
Centers for Disease Control and Prevention
Education Development Center, Inc.; Callen-Lorde Community Health Center; Hispanic...

Completed

No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks

HIV Infections

United States
Joanne Kurtzberg, MD
The Marcus Foundation

Terminated

hCT-MSCs for COVID19 ARDS

COVID | Corona Virus Infection | COVID19

United States
Hospital Israelita Albert Einstein
Libbs Farmacêutica LTDA

Recruiting

Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension (OPTION TREAT)

Hypertension

Brazil
Shanghai Changzheng Hospital
The First Affiliated Hospital of Anhui Medical University; Ruijin Hospital; First... and other collaborators

Unknown

Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension (BEAHIT)

Chronic Kidney Disease

China
Insel Gruppe AG, University Hospital Bern
University of Bern

Not yet recruiting

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention (INDAPACHLOR)

Kidney Stone

Switzerland
University of Abuja
Imperial College London; University College Hospital, Ibadan; University of Nairobi and other collaborators

Completed

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans (Creole)

Hypertension

Nigeria
Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Hypertension

China
Pfizer

Completed

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Healthy Participants

United States
Azidus Brasil

Completed

Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

Healthy Subjects

Brazil
Yonsei University

Completed

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Hypertension

Korea, Republic of
Novartis

Completed

Hypertension and Cardiovascular Risk Factors

HYPERTENSION
Sanofi

Completed

Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

Hypertension

Taiwan
Sanofi

Completed

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

Hypertension

Taiwan
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers

Healthy
Center for International Blood and Marrow Transplant...
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) (BMT CTN 1704)

Hematologic Malignancy

United States
Novartis

Completed

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

Hypertension

Switzerland, Germany
Novartis

Completed

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Hypertension

United States
Boehringer Ingelheim

Completed

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

Hypertension
Pfizer

Completed

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Hypertension | Blood Pressure, High

United States
Novartis

Completed

Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

Hypertension
Novartis

Completed

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension (ATTAIN)

Hypertension

United States
Novartis

Completed

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

Hypertension

Singapore
Damanhour University

Completed

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses) (PKVH PART II)

Healthy Normotensive Participants
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
Emory University
Incyte Corporation

Recruiting

Virtual Rehabilitation in HCT

Hematopoietic Cell Transplant

United States
Makerere University
Rakai Health Sciences Program

Unknown

Demand Creation for Couples' HIV Counseling and Testing

HIV/AIDS
Centers for Disease Control and Prevention
University of Illinois at Chicago; Howard Brown Health Center; Chicago Department... and other collaborators

Completed

Project ICARE: Intervening for Community Awareness, Respect, & Empowerment

HIV Infections

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older (TELSYS)

Hypertension
Novartis

Completed

A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

Hypertension

United States
Boehringer Ingelheim

Completed

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Hypertension

China
Boehringer Ingelheim

Completed

A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

Hypertension

Italy, Germany, Netherlands, France, South Africa, Belgium, Denmark, Finland, Ireland, Spain
University Hospital Tuebingen

Withdrawn

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Type 2 Diabetes Mellitus (T2DM)

Germany
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

Hypertension
Sanofi

Completed

ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination (ACTUAL)

Hypertension

Brazil, Tunisia, Argentina, Egypt, Mexico, Peru, Morocco, Colombia, Guatemala, Venezuela, Lebanon, Algeria, Ecuador, Panama, Saudi Arabia, United Arab Emirates
Novartis

Completed

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Hypertension

China
Novartis

Completed

A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

METABOLIC SYNDROME | HYPERTENSION | PRE-HYPERTENSION

United States
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

Hypertension

United States
Boehringer Ingelheim

Completed

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

Hypertension

China
Solvay Pharmaceuticals

Completed

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Hypertension | Type 2 Diabetes

France, Canada, Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Isolated Systolic Hypertension in the Elderly and Very Elderly

Isolated Systolic Hypertension

Germany
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Merck Sharp & Dohme LLC

Completed

Hyzaar Asia HEAALTH (0954A-950)

Hypertension
Yining Huang

Unknown

Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE)

Cerebral Small Vessel Diseases

China

3

Subscribe